[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 421 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  1st Session
                                 S. 421

 To prohibit Federal funding to the Wuhan Institute of Virology and to 
require a GAO study regarding Federal funds previously provided to such 
    institute or to entities affiliated with the Chinese Government.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           February 14, 2023

   Ms. Ernst introduced the following bill; which was read twice and 
             referred to the Committee on Foreign Relations

_______________________________________________________________________

                                 A BILL


 
 To prohibit Federal funding to the Wuhan Institute of Virology and to 
require a GAO study regarding Federal funds previously provided to such 
    institute or to entities affiliated with the Chinese Government.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Defund the Wuhan Institute of 
Virology Act''.

SEC. 2. PROHIBITION ON FEDERAL FUNDING TO THE WUHAN INSTITUTE OF 
              VIROLOGY.

    (a) In General.--No funds authorized or appropriated by Federal law 
may be made available to the Wuhan Institute of Virology for any 
purpose.
    (b) GAO Study and Report.--Not later than 2 years after the date of 
the enactment of this Act, the Comptroller General of the United States 
shall conduct a study and submit a report to Congress regarding the 
amount of Federal funds that were awarded or indirectly provided 
(whether purposely or inadvertently) during the 15-year period 
immediately preceding such date of enactment to--
            (1) the Wuhan Institute of Virology, including affiliated 
        researchers;
            (2) the People's Republic of China;
            (3) the Chinese Communist Party; or
            (4) any agency or instrumentality of the entities listed in 
        paragraphs (1) through (3).
                                 <all>